These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1786197

  • 1. In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude mice.
    Nio Y, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Kawabata K, Masai Y, Tun T, Fukumoto M, Tobe T.
    Biotherapy; 1991; 3(4):337-44. PubMed ID: 1786197
    [Abstract] [Full Text] [Related]

  • 2. Cytokines and pancreatic cancer. Sensitivity of xenotransplants of predominantly pancreatic carcinomas to rIFN-gamma and rTFN-alpha in nude mice.
    Kühl JS, Klapdor R, Bahlo M, Franke N, Kunde C, Arps H, Dietel M.
    Int J Pancreatol; 1989 Apr; 4(3):303-19. PubMed ID: 2503584
    [Abstract] [Full Text] [Related]

  • 3. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M, Altermatt HJ, Ris HB, Althaus U, Rüegg C, Liénard D, Lejeune FJ.
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [Abstract] [Full Text] [Related]

  • 4. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
    Inagawa H, Oshima H, Soma G, Mizuno D.
    J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
    [Abstract] [Full Text] [Related]

  • 5. Regression of human breast cancer xenografts in response to intralesional treatment with interferons alpha and gamma potentiated by tumor necrosis factor.
    Ozzello L, de Rosa CM, Cantell K, Kauppinen HL, Habif DV.
    J Interferon Cytokine Res; 1995 Oct; 15(10):839-48. PubMed ID: 8564705
    [Abstract] [Full Text] [Related]

  • 6. Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.
    Kido G, Wright JL, Merchant RE.
    J Neurooncol; 1991 Apr; 10(2):95-109. PubMed ID: 1716671
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
    Gatanaga T, Noguchi K, Tanabe Y, Inagawa H, Soma G, Mizuno D.
    J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298
    [Abstract] [Full Text] [Related]

  • 13. Effects of MAb BW 494/32 and rTNF-a/rIFN-g alone and in combination in nude mice bearing xenografts of human gastrointestinal/pancreatic carcinomas.
    Klapdor R, Schwarzenberg O, Kühl JS, Franke N, Bahlo M.
    Strahlenther Onkol; 1989 Jul; 165(7):549-50. PubMed ID: 2501886
    [No Abstract] [Full Text] [Related]

  • 14. Cytokines and pancreatic cancer. The effect of rIFN-gamma, HuLeIFN, rTNF-alpha, and LAK-cells on pancreatic and other gastrointestinal tumors in vitro.
    Kühl JS, Klapdor R, Mohr H, Arps H, Dietel M.
    Int J Pancreatol; 1989 Mar; 4(2):207-19. PubMed ID: 2498436
    [Abstract] [Full Text] [Related]

  • 15. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
    Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ.
    J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential antiproliferative activities of alpha- and gamma-interferon and tumor necrosis factor alone or in combinations against two prostate cancer xenografts transplanted in nude mice.
    van Moorselaar RJ, van Stratum P, Borm G, Debruyne FM, Schalken JA.
    Prostate; 1991 Jan; 18(4):331-44. PubMed ID: 1905403
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma.
    Lejeune F, Liénard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gérain J, Klaase J, Kroon B, Vanderveken J, Schmitz P.
    J Cell Biochem; 1994 Sep; 56(1):52-61. PubMed ID: 7806592
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    Bermudez LE, Young LS.
    J Immunol; 1988 May 01; 140(9):3006-13. PubMed ID: 2834450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.